- Home
- RVP vs BNGO Comparison
RVP vs BNGO Comparison
Compare RVP & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- BNGO
- Stock Information
- Founded
- RVP 1994
- BNGO 2003
- Country
- RVP United States
- BNGO United States
- Employees
- RVP N/A
- BNGO N/A
- Industry
- RVP Medical/Dental Instruments
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- RVP Health Care
- BNGO Industrials
- Exchange
- RVP Nasdaq
- BNGO Nasdaq
- Market Cap
- RVP 29.2M
- BNGO 24.3M
- IPO Year
- RVP 2001
- BNGO 2018
- Fundamental
- Price
- RVP $0.82
- BNGO $1.59
- Analyst Decision
- RVP
- BNGO Buy
- Analyst Count
- RVP 0
- BNGO 4
- Target Price
- RVP N/A
- BNGO $7.67
- AVG Volume (30 Days)
- RVP 229.4K
- BNGO 347.1K
- Earning Date
- RVP 11-14-2025
- BNGO 11-13-2025
- Dividend Yield
- RVP N/A
- BNGO N/A
- EPS Growth
- RVP N/A
- BNGO N/A
- EPS
- RVP N/A
- BNGO N/A
- Revenue
- RVP $38,161,712.00
- BNGO $27,426,000.00
- Revenue This Year
- RVP N/A
- BNGO N/A
- Revenue Next Year
- RVP N/A
- BNGO $24.54
- P/E Ratio
- RVP N/A
- BNGO N/A
- Revenue Growth
- RVP N/A
- BNGO N/A
- 52 Week Low
- RVP $0.56
- BNGO $1.50
- 52 Week High
- RVP $1.14
- BNGO $22.80
- Technical
- Relative Strength Index (RSI)
- RVP 40.91
- BNGO 30.62
- Support Level
- RVP $0.83
- BNGO $1.85
- Resistance Level
- RVP $0.89
- BNGO $1.85
- Average True Range (ATR)
- RVP 0.06
- BNGO 0.08
- MACD
- RVP -0.02
- BNGO 0.00
- Stochastic Oscillator
- RVP 8.99
- BNGO 17.78
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.